Phase I trial of myeloablative conditioning with 3‐day total marrow and lymphoid irradiation for leukemia
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Science"
DOI: 10.1111/cas.15611
Abstract: This prospective phase I trial aimed to determine the recommended dose of 3‐day total marrow and lymphoid irradiation (TMLI) for a myeloablative conditioning regimen by increasing the dose per fraction. The primary end‐point of this… read more here.
Keywords: day total; day; phase trial; total marrow ... See more keywords